This article has Open Peer Review reports available.
Ethical framework for the detection, management and communication of incidental findings in imaging studies, building on an interview study of researchers’ practices and perspectives
- Eline M. Bunnik1Email author,
- Lisa van Bodegom1,
- Wim Pinxten2,
- Inez D. de Beaufort†1 and
- Meike W. Vernooij†3, 4
© The Author(s). 2017
Received: 15 September 2016
Accepted: 19 January 2017
Published: 6 February 2017
As thousands of healthy research participants are being included in small and large imaging studies, it is essential that dilemmas raised by the detection of incidental findings are adequately handled. Current ethical guidance indicates that pathways for dealing with incidental findings should be in place, but does not specify what such pathways should look like. Building on an interview study of researchers’ practices and perspectives, we identified key considerations for the set-up of pathways for the detection, management and communication of incidental findings in imaging research.
We conducted an interview study with a purposive sample of researchers (n = 20) at research facilities across the Netherlands. Based on a qualitative analysis of these interviews and on existing guidelines found in the literature, we developed a prototype ethical framework, which was critically assessed and fine-tuned during a two-day international expert meeting with bioethicists and representatives from large population-based imaging studies from the United Kingdom, Germany, Sweden and Belgium (n = 14).
Practices and policies for the handling of incidental findings vary strongly across the Netherlands, ranging from no review of research scans and limited feedback to research participants, to routine review of scans and the arrangement of clinical follow-up. Respondents felt that researchers do not have a duty to actively look for incidental findings, but they do have a duty to act on findings, when detected. The principle of reciprocity featured prominently in our interviews and expert meeting.
We present an ethical framework that may guide researchers and research ethics committees in the design and/or evaluation of appropriate pathways for the handling of incidental findings in imaging studies. The framework consists of seven steps: anticipation of findings, information provision and informed consent, scan acquisition, review of scans, consultation on detected abnormalities, communication of the finding, and further clinical management and follow-up of the research participant. Each of these steps represents a key decision to be made by researchers, which should be justified not only with reference to costs and/or logistical considerations, but also with reference to researchers’ moral obligations and the principle of reciprocity.
Research groups worldwide are studying the human body making use of non-invasive imaging techniques, notably magnetic resonance imaging (MRI). On MR images, researchers will incidentally come across so-called incidental findings, findings that are beyond the aims of the study but may be of potential health or reproductive relevance to - otherwise healthy - research participants . Detection and feedback of incidental findings are a double edged sword: they may allow for timely treatment and thus lead to medical benefit, but may also harm research participants because of the risks, psychological burdens and costs of follow-up testing and (over)treatment [2, 3]. Not all abnormalities warrant clinical follow-up, [4–6] or lead to the possibility of procuring health benefits . Thus, incidental findings tend to place researchers before an ethical dilemma: to actively search for these or not, and to refer for further work-up or to remain silent.
The prevalence of clinically significant incidental findings among healthy participants is estimated around 2.7% in brain MRI, with a number needed to scan of around 37 for one finding deemed of clinical significance . Though the prevalence of incidental findings may be lower in children and adolescents than in the elderly, they are not extremely rare in the young [8, 9]. In imaging of other body parts (e.g. abdomen or whole-body), the frequency with which incidental findings are detected may be much higher [10, 11]. In Europe, large population-based cohort studies are currently underway, in which (tens of) thousands of healthy research participants are undergoing imaging of the body or brain – in the case of UK Biobank, even a hundred thousand [10, 12–16]. Large numbers of incidental findings can thus be expected in the next few years.
International guidelines for the detection, management and feedback of incidental findings in the context of research have, as of yet, been largely procedural and quite non-specific, and have allowed for a “range of options”  or a “spectrum of models”  to evolve for the handling of incidental findings [19, 20]. For instance, whereas in some studies, research scans are checked for image quality only and very limited feedback is given to research participants,  other groups conduct a full clinical review of all research scans by expert radiologists . Practices for the handling of incidental findings thus vary considerably across studies and research settings [20, 21].
Although current guidelines are non-specific in how incidental findings should be handled, they do agree on some important points. When abnormalities of potential clinical significance are being picked up by researchers, they should act [1, 19, 22, 23]. Further, researchers ought to consult with an expert (usually a radiologist) to confirm the imaging finding before informing the research participant [20, 24]. Moreover, a predesigned pathway for the handling of incidental findings, including expert consultation, should be in place and should be communicated beforehand with research participants, preferably as part of the informed consent process [1, 19, 22, 25]. Finally, the pathway should ideally be reviewed by an ethics committee or institutional review board . However, as general ethical frameworks are still lacking,  ethics committees may currently be insufficiently equipped to evaluate pathways for the handling of incidental findings within research protocols.
With the rise of the use of imaging techniques in research comes an urgent need for practical ethical guidance. Researchers need to know what adequate pathways for the handling of incidental findings look like. In this paper, we present a seven steps framework to be used by researchers and/or ethics review committees when setting up or evaluating pathways for the handling of incidental findings in imaging studies. Researchers will need to consider each of the seven steps of the framework, will need to decide how to give them shape in a pathway for the handling of incidental findings, and will need to justify these decisions, taking research participants’ moral expectations into account. The seven-step framework has been developed based on an interview study and an expert meeting on current practices for the handling of incidental findings.
This paper explores current practices for the detection, management and communication of incidental findings in neuroimaging and other research centres in the Netherlands, as well as - senior and junior - researchers’ perspectives on their moral obligations with regard to incidental findings. The approach taken consists of two components: an interview study and an expert meeting.
Respondents included in the interview study
Type of research centre
Population-based cohort study A
Population-based cohort study A
Population-based cohort study B
Neuroimaging centre A
Neuroimaging centre A
Neuroimaging centre A
Hospital-based imaging centre
Hospital-based imaging centre
Neuroimaing centre B
Neuromaging centre B
Neuroimaging centre B
Neuroimaging centre B
National screening programme A
National screening programme B
National screening programme B
National screening programme B
Biobank at academic hospital
The interviews were digitally recorded, transcribed verbatim and stored securely. Emotional responses (e.g. ‘sigh’ or ‘silence’) were also noted by the interviewer(s). This was done as deemed relevant by the interviewer, not done in any systematic way. Paper-based and basic word processing methods were used for data analysis. Interview transcripts were coded independently by two researchers (LvB and EB) using a constant comparative method,  which entails going back and forth between transcripts and codes and themes in an ongoing, iterative process . Codes were assigned, regrouped into higher-order themes, and refined through multiple readings and re-readings. Discrepancies were resolved through discussion. Main themes were identified, and were used to collect and regroup transcript fragments.
Based on the results of our interview study, we have drawn up an ethical framework for the detection, management and communication of incidental findings detected through imaging in research, consisting of seven points that should be considered prior to the start of every imaging study (see Discussion). This framework was presented and corroborated at a 2-day international expert meeting, organised at the Department of Medical Ethics and Philosophy of Medicine in Rotterdam in 2015, in which representatives were gathered from large European population-based cohort studies as well as from various research centres in the Netherlands. The attending experts (n = 14) came from the Netherlands, the United Kingdom, Germany, Sweden and Belgium. Apart from (neuro)radiologists and (neuro)science researchers, the group also involved ethical and legal experts. Some attendants were not involved in large population-based studies, but in neuroscience or genomics studies. The main aims of the expert meeting were to share best practices and moral considerations, and to discuss our ethical framework for the handling of incidental findings in research. Based on the expert meeting, we fine-tuned, complemented and adjusted our framework. The outcomes of the expert meeting will be presented in the discussion.
First, we give an impression of the range of pathways that currently exist in the Netherlands for the handling of incidental findings. Then we outline how and why our respondents made choices about the set-up of their adopted pathways. Finally, we report on our respondents’ views on researchers’ moral obligations.
Pathways and policies for the handling of incidental findings differ across the Netherlands
Pathways and policies for the detection, management and communication of incidental findings were variable: some centres had detailed pathways in place, outlining what to do and whom to contact in case abnormalities were detected, while other centres were still in the process of setting up policies or pathways for the handling of incidental findings, or were struggling with incidental findings on a case-by-case basis. While most respondents supported policies that ensured that potentially relevant incidental findings are reported back to research participants, others maintained limited or ‘no feedback’ policies. In four centres, internal documents described standard operating procedures researchers or radiographers were expected to follow when confronted with abnormalities. While these procedures were largely similar (e.g. scans should be saved in specific ways and on specific locations, a person centrally handling incidental findings should be contacted, the researcher should wait for a confirmatory response from a (neuro)radiologist), there were also differences with regard to whether or not researchers or radiographers were required to make additional diagnostic-quality scans of potentially abnormal brains, and whether or not they were allowed to inform the research participant about the finding during the scanning process.
PhD-student a: You’re not really going to look for things, right? […] But if you really see something, you report that. That’s what the protocol says.
PhD-student b: But isn’t there a hospital-broad protocol that says: ok, this is how you check for incidental findings?
PhD-student c: No, you don’t really have to check, right? It is an incidental finding when you come across something.
PhD-student a: No, that’s right, there is no need to check. But if you see something, you report. That’s the protocol. But it’s not like everyone will look at scans in the same way or search for things…
PhD-student c: I think it’s right not to look for things.
PhD-student a: So you make a screenshot?
PhD-student c: Only if [participants] ask. We don’t routinely offer it to them.
PhD-student b: You don’t routinely offer it to them? We always just give it to them.
PhD-student c: What? A screenshot or a CD?
PhD-student b: A CD with everything […]
PhD-student a: So you have all the images to scroll through?
PhD-student b: Yes […] Does your centre really advise against that?
PhD-student c: Definitely. I am told not to even show the computer screen to participants […]
PhD-student b: They really like it […] Especially since it is about their own brain […] One participant had even printed an image on his T-shirt!
(PhD-students a and c (respondents 7 and 8) work at a hospital-based imaging centre, PhD-student b (respondent 5) works at an independently located neuroimaging centre.)
Pathways: seven steps
After learning from all of our respondents about various existing pathways for the detection, management and communication of incidental findings used in several research centres across the Netherlands, we identified seven crucial steps in these pathways: anticipation of findings, information provision and informed consent, scan acquisition, review of scans, consultation on detected abnormalities, communication of the finding, and further clinical management and follow-up of the research participant. Together these seven steps form an ethical framework for the handling of incidental findings. Below, the findings from our interview study will be presented along the lines of this seven step framework. In each of these seven steps, researchers have to make choices with regard to the pathway for the handling of incidental findings, and have to justify these choices. These choices and their justifications were the topic of many of our discussions with respondents.
Anticipation of incidental findings
We’ve been here for twelve years by now, we have [acquired brain scans from] 3,000 people annually. There have been [a few] incidental findings, but no one has died from them. […] The panicky idea that we could be saving lives by detecting incidental findings, I am not buying that. (research manager at neuroimaging centre b, respondent 10)
So there is a big problem, I can tell you that. As a doctor you cannot lay awake at night […] But no one should deny that this is a big problem. (neuroradiologist at population-based cohort study a, respondent 1)
Really, we’re talking about one case in five years, or something. […] That is what the fuss is all about. Everyone is really focused on this. It is different with the elderly. Maybe you should [discuss incidental findings] with the elderly, but not with the young. (principal investigator (PI) at neuroimaging centre a, respondent 4)
We have really made a list that explicates which findings we report and which findings we intentionally do not report. And everything in between, everything else we encounter, we will have to discuss anew. (neuroradiologist population-based cohort study b, respondent 3)
I always just stick to this, together with the rest of the [hospital], that it should be life-threatening and treatable before you are going to burden someone with [an incidental finding]. (director of a biobank, respondent 17)
Information and informed consent
Incidental findings are of such little relevance that you don’t even need to discuss them with subjects. You don’t even need to talk about incidental findings in the informed consent. Because they have no consequences in the young. (PI at neuroimaging centre a, respondent 4)
I am wondering whether [pre-scan information on incidental findings] may cause more harm than good, because you may deter [research participants] more, so that they may no longer be willing to participate. And they may overestimate the chance that something will be found. (PhD-student a at neuroimaging centre b, respondent 11)
At most centres, however, researchers are obliged by internal policies to inform research participants that incidental findings may be detected. As part of the informed consent, research participants will have to agree to receiving feedback about any clinically relevant incidental finding. Often, participants will also have to agree to the researchers notifying their primary care physician in case an abnormality is detected.
Look, you can say: ‘This is scientific research, no medical doctor is going to be looking at [these scans], no clinical eye, there is no such thing as gaining medical benefit from this’. But then you’re also saying: ‘If we do find something very odd, we will tell you.’ Well, then you’re dithering: we’re not looking, but we’re looking. This is an ambivalent message, if you ask me. (primary care physician a, respondent 19)
Well, I think it is important to explain [that you are not looking] to research participants, but I do think that people will think, in the back of their minds: ‘Oh, but if there really is something wrong, those [researchers] will see that, and then they will send [the scan] on [to an expert radiologist]. I do think that [scanning] offers false reassurance. (PhD student at a hospital-based imaging centre, respondent 8)
Despite serious attempts to downplay participants’ expectations with regard to clinical review during the informed consent process, respondents felt that many research participants continue to assume that apparent abnormalities will be detected and acted upon by researchers.
It is an often recurring issue, in discussions with participants, too. […] They will always be asking: ‘Well? Does everything look normal?’ (PhD-student at neuroimaging centre a, respondent 6)
The researchers perform the scanning themselves. They will have to become certified users, but that has only to do with technical skills and not with the assessment of the brain at an anatomic level. So these are not people who know what a brain looks like. So they either detect something by coincidence or they don’t. There is no obligation on the part of the researcher to scroll through every anatomical scan, slice by slice, to see is there is something wrong. (PI at neuroimaging centre b, respondent 9)
Some researchers feel that they should (briefly) check research scans for abnormalities anyway, while operating the scanner, whereas others do not. Research scans are thus ‘looked at’ differently by different researchers.
Review of scans
The extent to which research centres review brain scans varies. Some centres ask researchers or radiographers to assess the quality of the scan only, on the spot, during scan acquisition: have the required sequences been made, are all required measurements or biomarkers present and clearly visible? In those centres, no arrangements have been made for the review of research scans for abnormalities, and PIs may tell junior researchers or radiographers that the detection of incidental findings is something to be avoided. These are usually centres in which only functional imaging sequences with limited structural sequences (only T1-weighted) are acquired, the diagnostic utility of which is limited. Such images do not easily allow for the adequate detection or clinical interpretation of certain incidental findings, such as aneurysms, although large tumours may be spotted.
Other centres have set up a system in which all diagnostic-quality research scans are reviewed for abnormalities, either directly by an expert neuroradiologist or indirectly, after possible incidental findings have been flagged by research personnel. One centre especially trains their PhD-students (most of them have a medical background and are training to become radiologists), through a training programme that was developed in-house, to distinguish normal brains from abnormal brains. When the PhD-students detect an abnormality, they put it on the agenda of a two-weekly team discussion, led by an expert neuroradiologist. The expert neuroradiologist will explain the abnormality to the researchers and decide whether or not to report the finding to the research participant.
This is a seven-year-old child. The scans had not been reviewed before. Because, well, that is because of a backlog in reviewing. Because, you know, it is a lot of work. And it is work that is unpaid. No reimbursement. A year later we are analysing these images for a scientific research question, and the researcher is saying: ‘Hey, something is wrong here’. We’re seeing this asymmetry [possibly a tumour]. (neuroradiologist at population-based cohort study a, respondent 1)
Consultation on detected abnormalities
Many centres instruct researchers that when they do detect an abnormality, they must contact the principle investigator or manager of the research centre. The PI or the manager may not be an expert (neuro)radiologist him- or herself, but he or she is in a position to decide whether or not consultation by an expert will be necessary. It is generally agreed upon that incidental findings should be confirmed by an expert (usually a radiologist) before the research participant is informed.
With [referring the research participant for expert consultation] you will needlessly trouble the research participant. If it may not affect the participant’s daily life, you will have to ask yourself: are you really going to start an entire procedure, in which you’re asking the neurologist and the primary care physician for their opinion? This will only upset the research participant, often for no reason. (primary care physician b, respondent 20)
Well, we choose not to have radiologists [routinely] look at scans. That is too expensive. We don’t do that. So it becomes an incidental finding. […] Then you need someone [an expert radiologist] who can assess whether it is [an abnormality that needs reporting] or not. Well, you go and try to find such a person. (research manager at neuroimaging centre b, respondent 10)
Communication of the incidental finding
We cannot afford feeding back this information. […] I cannot do it myself […] because I am not medically trained. […] So a physician would have to be arranged to feed the information back. And for those reasons we have decided: we’re not going to do it. (director of a biobank, respondent 17)
I strongly support that [IFs are reported through primary care physicians]. The primary care physician knows the social situation of the patient, knows the co-morbidity, has a better understanding of [the patient…] I think the primary care physician is the right person. Just to take the context into account when communicating with the patient, but also for the follow-up. (primary care physician a, respondent 19)
We offer participants the chance to choose against acting upon an incidental finding. So that we do not send them into the medical ‘circus’ against their wishes. So we always ask the question [whether or not they want to follow up on the finding]. We do not seek contact with the primary care physician before talking to the participant him- or herself, because that feels like sharing private information behind someone’s back. The participant him- or herself should control that information. So on the phone I always ask: ‘Now, I have told you this, and probably your primary care physician would like to know about this, too. Are you OK with that?’ (neuroradiologist at population-based cohort study b, respondent 3)
In practice, very few research participants keep the researcher from letting their primary care physician know about the finding.
Further clinical management and follow-up
In some cases, hospital-based or hospital-affiliated respondents have made prior arrangements or maintain relationships with clinical specialists, so that whenever they notify a research participant about an incidental finding, an appointment with a clinical specialist can be arranged within a timeframe of a couple of days. This approach, it is thought, will reduce uncertainty and anxiety in research participants. Other respondents indicated that they simply refer research participants to their primary care physicians, who may then arrange a meeting with a clinical specialist for them, if deemed necessary.
What I have heard […] is that it all went well and that, given the circumstances, the information [about the incidental finding] has been received well. So that is what we hear back. But because we are not in the role of the physician, we don’t get to hear any details. So you will just have to assume that it went well. (director of screening programme a, respondent 13)
We have had that question from the ethics review committee: ‘Can you not follow up on these research participants?’ But when they are in the care of a physician, [the physician] will have his professional confidentiality, and we are not medical doctors. We are not a medical centre, so a doctor can tell us nothing, unless the research participant indicates that he wants his doctor to inform us, but the research participant will have other things on his mind. (PI at neuroimaging centre b, respondent 9)
At one point we had referred thirty people or so to the endocrinologist [for small pituitary cysts]. And then there were hormone examinations and new scans. After that we drew up the balance sheet and it turned out that none of these thirty people were suffering from hormone disorders. […] So we decided in a team conference that it was probably not that useful to refer people with such an abnormality. (neuroradiologist at population-based cohort study b, respondent 3)
During our interviews, we sought to elucidate researchers’, research managers’ and other stakeholders’ views of the moral responsibilities of researchers. Do they think researchers are morally required to ‘look for’ incidental findings? Do they think they are to be blamed when they ‘miss’ incidental findings? What are researchers’ moral considerations regarding the detection, management and communication of incidental findings? What do they perceive to be their (implicit) mission statements as researchers?
Researchers’ responsibilities to look for incidental findings
You have to think about what the responsibilities are of someone who is holding the materials and looking at the results of those tests. This [researcher] is not trained to find such things. So if he is alert, he’ll notice, but you can’t blame him if he’s not alert. (director of a biobank, respondent 17)
This woman [whose mother recently died] came to the clinic to see the neurosurgeon and tells the neurosurgeon: ‘My mother participated in a scan study 8 months ago. Have they not seen anything?’ So the neurosurgeon calls the researcher and asks: ‘Have you not seen the tumour?’ So we go and look at the scans […] Here you see a small aberration. These images had been reviewed. [The aberration was] not detected. So we have to tell this patient: ‘Yes, we checked the images again, and in retrospect we can see something. […] Yes, we can see it now, but we missed it then […] And now she died. (neuroradiologist at population-based cohort study a, respondent 1)
We call it the retroscope: when you know where something has been found, when you look back exactly in that place, you increase your sensitivity to find something there. Then we said: if we’re looking at both scans, we can now see that something was amiss on that first scan, but if we had only the first scan […] we couldn’t have seen it then. It is not like we missed something. (neuroradiologist at population-based cohort study b, respondent 3)
Researchers’ responsibilities to report incidental findings
You cannot do that: keeping things from people. Not the things which are relevant enough to report to a primary care physician. (primary care physician b, respondent 20)
Think about this: at a certain point in time this person develops a headache or something, and we all know how long it takes for a patient to go through the medical parade before [doctors] order a brain scan, and it turns out to be a cyst. And we would have known all along [that it was a cyst…] I do understand that you shouldn’t worry people unnecessarily, but on the other hand I do think it would be strange to withhold this information from a research participant. (neuroradiologist at population-based cohort study a, respondent 1)
The moral obligation, I think, is also to build some form of protection against those five dots on the MRI that mean nothing but could haunt people for the rest of their lives. (director of a biobank, respondent 17)
Researchers’ care obligations
I believe [it has to do with] integrity. Like: this is how we deal with our research participants. We’re not just hauling them in and out of our scanners, and that’s it, you get paid or you get [university] credits [in case of students]. We take a broader perspective. This is not about care per se, but it is about, well, concern. We’re not in a care relationship – these are not patients. They are research participants, for whom you do take responsibility. (PI at neuroimaging centre a, respondent 4)
[Research participants] expect you to feel responsible. You can try to demarcate and say: ‘Well, this is research, we are only looking at the science, we’re not looking after your health, but that is not how life works. People expect you to [look after their health]. There are expectations. (neuroradiologist at population-based cohort study a, respondent 1)
The principle of reciprocity
I think it’s good [if researchers feed results back], because [research participants] value that. I think it’s a type of exchange: you participate and you want an answer, then you shall naturally have that answer. [It is] a social interaction. (neuroradiologist at population-based cohort a, respondent 1)
We know that most people participate because they see this as a [free medical] check-up. (primary care physician a, respondent 19)
And you notice […] that many people participate in research, secretly with the idea that they will learn about serious abnormalities in the brain. (PI at neuroimaging centre b, respondent 9)
Other respondents chose to clearly inform research participants beforehand that the imaging study does not function as a health check, and will not lead to medical benefit for participants.
Existent ethical and legal guidance, so far, has suggested that a pathway for handling incidental findings should be in place at the outset of the research program, evaluated by an ethics committee and communicated to research participants as part of the informed consent process [1, 26]. However, no specific criteria have been established for the setting up of such a pathway or for the evaluation of pathways within study protocols. Is there really nothing more to say – normatively – about pathways for handling incidental findings, over and above that they should be present and should be evaluated on a case-by-case basis? Based on our interview study and expert meeting, we contend that there is: any responsible pathway in a high-income country must, at minimum, adequately address the seven steps listed in our framework. It should be noted that, as this study was conducted in the Netherlands, the outcomes and the resulting ethical framework cannot be translated directly to other countries, such as low and middle-income countries.
The seven steps of the framework need not and cannot be addressed in precisely the same manner in all research studies. Given the reported variability between research settings, it will hardly be possible to converge on a single ethical standard for the design of pathways for the handling of incidental findings in (brain) imaging research [23, 29]. Highly demanding pathways may not be feasible or desirable across all research settings, e.g. in low-resource countries. Moreover, in research settings in which only functional brain imaging is acquired for non-medical purposes, the chances of detecting interpretable, clinically relevant incidental findings are slim. It may be unnecessarily burdensome to trouble volunteers with information on the possibility – however small – of incidental findings and the implications thereof. Ethical guidance will thus have to be differentiated .
The seven steps framework and minimum requirements for pathways for the detection, management and communication of incidental findings in research
The seven steps framework
Anticipation of incidental findings
Incidental findings should be anticipated.
In large-scale imaging studies, lists should be made of anticipated incidental findings, stipulating their management.
Information provision and informed consent
As part of the informed consent process, research participants should be informed about the possibility that incidental findings may be detected, and about the pathway for handling such findings.
Research participants should be given the opportunity either to opt out of receiving information about incidental findings or to withdraw from the study.
Researchers need not acquire any (diagnostic-quality) scans in addition to the scans that are necessary for the research purposes.
Radiographers should be instructed whether and to what extent to review scans for abnormalities during scan acquisition
Review of scans
In studies in which diagnostic-quality images are acquired, some form of routine review of research scans should be arranged.
Consultation on detected abnormalities
Detected abnormalities should be confirmed by experts (i.e. radiologists) before they are reported to the research participants.
Researchers should make prior arrangements with experts.
Communication of the incidental finding
Policies for the communication of the incidental finding to the research participant should align with national regulations and customs.
Further clinical management and follow-up of the research participant
In case of serious incidental findings, researchers should take responsibility for the clinical follow-up of the research participant (i.e. through adequate and timely referral).
Researchers should make prior arrangements with relevant clinicians.
Our respondents recognised that researchers are held by special moral responsibilities with regard to the detection and careful handling of incidental findings. This is consistent with the entrustment model of the researcher-research participant relationship [33, 34], which sets out role-specific ancillary care obligations for researchers. These obligations follow from the informed consent process, through which research participants entrust aspects of their health to the researcher. Based on this ‘partial entrustment’, researchers have a duty of rescue towards research participants that is stronger than that of ordinary citizens towards one another [34, 35], and are expected to care for entrusted aspects of research participants’ health (e.g. the brain). Researchers would thus have a strong role-specific moral imperative to act upon clinically relevant incidental findings detected during imaging.
In addition, the principle of reciprocity featured prominently in our interviews with researchers (and in our interviews and focus groups with research participants, which will be reported separately), and gained traction during our expert meeting. Our respondents believed that an adequate response to incidental findings is an expression of respect for research volunteers’ contribution to scientific research. Studies have shown that many research participants expect that incidental findings, if present, will be detected and will be acted upon , and have a strong preference for receiving information about incidental findings [36–38]. Based on the principles of respect for (the autonomy of) research participants and of reciprocity, researchers may have reasons to check for abnormalities when they can.
Ethics review committees will have an important part to play in shaping researchers’ responsibilities, by evaluating and refining pathways for the handling of incidental findings within research protocols. The seven steps framework can help guide ethics committees’ deliberations. In addition, we will now provide some considerations to help determine the adequacy of researchers’ decisions with regard to the management of incidental findings. These considerations reflect current ethical guidance and best practice, and although such high standards may not be achievable for all research groups at present, they do set an example. Furthermore, based on ethical discussions in the literature, our interview study and expert meeting, we outline some minimum requirements for each of the seven steps (see Table 2).
Anticipation of findings
There is an increasing body of literature showing that incidental findings can and should be anticipated [10, 19, 26, 39]. Researchers who are involved in setting up an imaging study should acknowledge that incidental findings may occur. Researchers should assess the type and the frequency of findings to be expected, based on the type of scans that will be acquired and the study population. For large-scale studies in which diagnostic-quality scans are acquired, it is considered best practice to determine, prior to the start of the study, which (types of) findings, if detected, will or will not be reported. Representatives of large population-based studies who attended our expert meeting recounted that their respective research groups had agreed upon a list of findings to be reported and a list of findings not to be reported. They had established multidisciplinary panels, in which radiologists and clinicians worked together to develop such lists. Some studies have used the Rotterdam Study protocol for the handling of incidental findings , which contains a list for brain MRI, as a model. In drawing up a list of anticipated incidental findings to be reported, the clinical validity and utility of the findings  should be central criteria. This does not imply that information should only be returned if it pertains to diseases that can effectively be treated.
There are limits to the utility of lists: not all incidental findings can or need be anticipated. Attendants at our expert meeting reported that incidental findings that are not anticipated - and therefore not included in lists - are discussed on a case-by-case basis in multidisciplinary panels. Also, such panels serve to evaluate and revise the lists over time, as experience with incidental findings accumulates within studies.
Information provision and informed consent
It is generally agreed upon that as part of the informed consent process, research participants should be informed about the possibility that incidental findings can be detected and about the study’s pathway for the handling of incidental findings , including when and how research participants will be informed about an incidental finding, if detected. Ideally, research participants should be given the opportunity to consent to research participation while opting out of receiving information about incidental findings [19, 35, 36, 41]. Allowing participants to opt out helps to avoid unnecessary pressure to learn about - possibly unwanted - health-related information. Researchers or ethics committees may wish to qualify such an opt-out option, so that, if feedback of an incidental finding were necessary to prevent serious harm to the research participant , an exception could be made and the finding could be reported anyway. This option is called a ‘conditional opt-out’ option. Experts who attended our meeting indicated that generally only a small minority of research participants chooses to opt out of receiving information about incidental findings, and reported that it should be feasible to check the informed consent form first for research participants’ stated preferences, before contacting them.
Researchers must inevitably decide in advance which sequences will be acquired during the study. Current guidance suggests that researchers are not required to make any additional scans for the purposes of increasing the likelihood of detecting incidental findings . Thus, the scanning protocols should simply be the minimum required to answer the research question . This implies that researchers can perfectly well acquire scans of (very) limited diagnostic utility only. This was corroborated in our expert meeting. Further, radiographers or researchers who are performing the scans should be instructed whether or not to review scans during scan acquisition, and to what degree, for the presence of abnormalities. It should be clear to radiographers or researchers who are performing the scans, what is expected of them during scan acquisition.
Review of scans
Traditionally, there has not been any moral obligation for researchers to ‘hunt’ or actively look for incidental findings when conducting research [26, 34]. Many respondents within our interview study did not support a duty to look for abnormalities. By contrast, however, attendants at our expert meeting agreed that it is currently best practice to arrange some form of routine review of research scans. The NIH, for instance, requires that on its campuses, all research scans are “examined by a qualified and experienced member of the research team” . Also the UK Medical Devices Agency (MDA) recommends that all volunteer MRI examinations are routinely reported by a radiologist . The international Mind Research Network provides routine review for its members by contracted board-certified neuroradiologists . Some studies make use of a two-step approach to routine review of scans, including a first step in which trained researchers (radiologists in training) review scans for abnormalities, and a second step in which an expert radiologist clinically reviews suspect scans . Though for some research centres, especially those that are not hospital-based or hospital-affiliated, it may be logistically and/or financially difficult to arrange routine review of scans, the costs need not be prohibitive . Further, when scans acquired are not of diagnostic quality (e.g. fMRI scans), routine review may not be feasible or valuable. However, in large imaging studies in which diagnostic-quality scans are acquired, some form of routine review should be performed . This recommendation was corroborated in our expert meeting. This implies that in some research settings, researchers may be expected to actively look for abnormalities, which raises questions about a ‘duty to hunt’ incidental findings.
Consultation on detected abnormalities
When an abnormality is detected, the research scan should be assessed by an expert , usually a radiologist. The radiologist is consulted first to verify that an abnormality is indeed present on the scan and to provide a diagnosis. Then, the radiologist will have to determine whether or not the abnormality is of clinical relevance to the research participant, and whether or not it should be reported to the research participant. This judgment should preferably be made not by the radiologist alone, but in consultation with a relevant clinician. When a list of findings (not) to report has previously been established (in collaboration with relevant clinicians), this list can serve as a basis for the radiologist’s judgment of clinical significance. To many ethics committees, confirmation by an expert radiologist is an explicit requirement for any feedback of incidental findings to research participants . This requirement is applicable to all research contexts, and implies that even for small-scale scan studies, research teams should establish contact with a radiologist who can be consulted in case of a presumed abnormality. A pathway for consultation needs to be in place prior to the start of the study.
Communication of the incidental finding
In some countries, the communication of a clinically relevant incidental finding to a research participant must legally be undertaken by a licensed physician. In these countries, one or more physicians should preferably be part of the research team of large-scale imaging studies, in which incidental findings are expected to occur frequently. In small-scale studies or in studies in which only sequences lacking diagnostic utility are acquired, it may suffice for the research team to make prior arrangements with regional primary care physicians or medical specialists, who can be called upon in case an incidental finding is detected. The feedback of incidental findings will then take place via the primary care physician or general practitioner of the research participant [19, 46]. In other jurisdictions, researchers (who are not physicians) may report their findings directly to research participants and advise them to consult with a primary care physician or a medical specialist. Some of our respondents felt that it would violate the privacy rights of the research participant to ‘go behind their backs’ and inform their primary care physicians without informing them first. This has been suggested in other studies, too . Experts attending our meeting stated that therefore, in their studies, research participants are contacted directly and verbally (over the phone) by a physician who is part of the research team. In some countries, other experts indicated, a written letter would be the customary manner in which first contact is made with the research participant about the incidental finding. Most attendants agreed that although serious findings should preferably be discussed face-to-face with the research participant , in their experience, it is possible to discuss incidental findings adequately over the course of one or more phone calls, provided that follow-up clinical care is offered in a timely manner.
Further clinical management and follow-up of the research participant
Attendants at our expert meeting agreed that researchers should take responsibility for the follow-up of the research participant. They are expected to prevent or minimize harm in research participants, but should also show respect for research participants . Moreover, they should provide the ancillary care of returning clinically relevant incidental findings . It can be argued that a certain degree of care entails that researchers cannot merely inform research participants about a potentially significant finding, they must also support them in addressing that finding. As researchers themselves may not be in the position to address the finding, they should help research participants find physicians who can. At minimum, researchers must refer the research participant to a relevant clinician, and must make the research scan and/or the radiologist’s report available. Ideally, the research team will have made prior arrangements with relevant clinicians in an associated hospital or elsewhere in the region, such that, whenever an incidental finding is detected, the research participant can be seen in a matter of days. Especially when the finding is serious and/or requires urgent medical attention, clinical follow-up should be available to research participants in a timely manner. The research team should preferably arrange some form of evaluation of the clinical follow-up of research participants, with the aim of further improving the pathway for the handling of incidental findings.
The seven steps described above will interact with one another. For example, the type of scans acquired (i.e. diagnostic-quality or not) will influence the likelihood that clinically relevant incidental findings are detected and therewith, will determine whether or not it is sensible to arrange routine clinical review of research scans. In studies in which diagnostic-quality scans are made, much more demanding pathways for the handling of incidental findings will be required than in studies in which sequences are acquired of limited diagnostic utility. After all, in the former, incidental findings will be frequent and interpretable, and, when clinically relevant, will require action on the part of the researcher. The line of action to be undertaken by researchers who acquire diagnostic-quality research scans, should be carefully anticipated, agreed upon, and assessed by an ethics review committee. Researchers and ethics review committees should increase their focus on the careful handling of incidental findings detected through imaging in research, so that ad hoc decision-making can be avoided and that research participants can know, in advance, what to expect with regard to incidental findings.
This paper presents an ethical framework consisting of seven steps, in which researchers should make decisions about the design of a pathway for the handling of incidental findings prior to the start of their imaging study. Given the variability among research settings, the framework does not prescribe how - or what - decisions should be made. The framework does point out that - and where - decisions must be made, and requires researchers to justify these decisions based not only on cost and feasibility considerations, but also on current best practices and research participants’ moral expectations.
Ethics review committees have the important task of evaluating pathways for the detection, management and communication of incidental findings within imaging studies. Whereas, as of yet, ethics committees have commonly required that a pathway be in place for the handling of incidental findings, they have not always specified what that pathway should look like. With this framework and the considerations offered in this paper, we aim at assisting ethics committees in the assessment of the appropriateness of proposed pathways. The development of consistent, transparent and appropriate pathways will be indispensable to maintain public trust in the coming years, as research imaging will affect thousands of research participants worldwide. In research contexts in which diagnostic-quality scans are acquired, appropriate pathways for the handling of incidental finding will require additional effort, funding and care on the part of the researchers. This additional effort, however, is not a reason to neglect incidental findings. Rather, it is necessary to meet the principle of reciprocity, as it is part of researchers’ responsibilities to protect the interests of research participants.
The authors would like to thank all respondents of the interview study and the attendees at the two-day international expert meeting for their valued input, and dr. Jan Heeringa, prof.dr. Aad van der Lugt and prof.dr. Albert Hofman of the Rotterdam Study for the discussions with which they contributed to the research project.
This work is a result of the research project ‘Previously Healthy? An ethical approach of incidental findings through imaging in research’ with project number ZonMw 731010004, which was financed by the Netherlands Organisation for Scientific Research (NWO).
Availability of data and materials
The datasets generated during and/or analysed during the current study are not publicly available for reasons of respondents’ privacy but are available from the corresponding author upon reasonable request. The datasets are in Dutch.
LvB and EB conducted the interviews and analysed the transcripts. EB drafted the manuscript. WP, IdB and MV made substantial contributions to the conception and design of the study and/or to the revision of the manuscript. All authors have read and approved the final manuscript. IdB and MV contributed equally to the study.
The authors declare that they have no competing interests.
Consent for publication
Consent to the recording, transcription and publication of the interview study was obtained verbally from respondents, under the condition of anonymisation.
Ethics approval and consent to participate
As the qualitative research reported in this manuscript, conducted among researchers and other professionals, does not involve human subjects research according to Dutch legislation, ethics approval and/or informed consent to participation are not applicable.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, et al. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics. 2008;36:219–48.View ArticleGoogle Scholar
- Royal JM, Peterson BS. The risks and benefits of searching for incidental findings in MRI research scans. J Law Med Ethics. 2008;36:305–14.View ArticleGoogle Scholar
- Grossman RI, Bernat JL. Incidental research imaging findings: pandora’s costly box. Neurology. 2004;62:849–50.View ArticleGoogle Scholar
- Orme NM, Fletcher JG, Siddiki HA, Harmsen WS, O’Byrne MM, Port JD, et al. Incidental findings in imaging research: evaluating incidence, benefit, and burden. Arch Intern Med. 2010;170(17):1525–32.View ArticleGoogle Scholar
- Illes J, Rosen AC, Huang L, Goldstein RA, Raffin TA, Swan G, et al. Ethical consideration of incidental findings on adult brain MRI in research. Neurology. 2004;62:888–90.View ArticleGoogle Scholar
- Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA. 1999;282:36–9.View ArticleGoogle Scholar
- Morris Z, Whiteley WN, Longstreth WT, Weber F, Lee Y-C, Tsushima Y, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016.View ArticleGoogle Scholar
- Jordan LC, McKinstry RC, Kraut MA, Ball WS, Vendt BA, Casella JF, et al. Incidental findings on brain magnetic resonance imaging of children with sickle cell disease. Pediatrics. 2010;126:53–61.View ArticleGoogle Scholar
- Reneman L, de Win MML, Booij J, van den Brink W, den Heeten GJ, Freling N, et al. Incidental head and neck findings on MRI in young healthy volunteers: prevalence and clinical implications. Am J Neuroradiol. 2012;33:1971–4.View ArticleGoogle Scholar
- Hegenscheid K, Seipel R, Schmidt CO, Völzke H, Kühn J-P, Biffar R, et al. Potentially relevant incidental findings on research whole-body MRI in the general adult population: frequencies and management. Eur Radiol. 2013;23:816–26.View ArticleGoogle Scholar
- Morin SHX, Cobbold JFL, Lim AKP, Eliahoo J, Thomas EL, Mehta SR, et al. Incidental findings in healthy control research subjects using whole-body MRI. Eur J Radiol. 2009;72:529–33.View ArticleGoogle Scholar
- Ikram MA, van der Lugt A, Niessen WJ, Koudstaal PJ, Krestin GP, Hofman A, et al. The Rotterdam scan study: design update 2016 and main findings. Eur J Epidemiol. 2015;30:1299–315.View ArticleGoogle Scholar
- Petersen SE, Matthews PM, Bamberg F, Bluemke DA, Francis JM, Friedrich MG, et al. Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches. J Cardiovasc Magn Reson. 2013;15:46.View ArticleGoogle Scholar
- Bamberg F, Kauczor H-U, Weckbach S, Schlett CL, Forsting M, Ladd SC, et al. Whole-body MR imaging in the German national cohort: rationale, design, and technical background. Radiology. 2015;277:206–20.View ArticleGoogle Scholar
- Håberg AK, Hammer TA, Kvistad KA, Rydland J, Müller TB, Eikenes L, et al. Incidental intracranial findings and their clinical impact; The HUNT MRI Study in a general population of 1006 participants between 50-66 years. PloS One. 2016;11:e0151080.View ArticleGoogle Scholar
- Ru Zhao Y, Xie X, de Koning HJ, Mali WP, Vliegenthart R, Oudkerk M. NELSON lung cancer screening study. Cancer Imaging. 2011;11:S79–84.View ArticleGoogle Scholar
- Illes J, Kirschen MP, Edwards E, Bandettini P, Cho MK, Ford PJ, et al. Practical approaches to incidental findings in brain imaging research. Neurology. 2008;70:384–90.View ArticleGoogle Scholar
- Booth TC, Jackson A, Wardlaw JM, Taylor SA, Waldman AD. Incidental findings found in “healthy” volunteers during imaging performed for research: current legal and ethical implications. Br J Radiol. 2010;83:456–65.View ArticleGoogle Scholar
- Representatives of Research Imaging Centres, Professional Societies, Regulatory Bodies, Funding Organisations, Royal Colleges involved in research imaging and Patient Organisations, in the UK. Management of Incidental Findings Detected During Research Imaging. London: SINAPSE and the Royal College of Radiologists; 2011.Google Scholar
- Illes J, Kirschen MP, Karetsky K, Kelly M, Saha A, Desmond JE, et al. Discovery and disclosure of incidental findings in neuroimaging research. J Magn Reson Imaging. 2004;20:743–7.View ArticleGoogle Scholar
- Booth TC, Waldman AD, Wardlaw JM, Taylor SA, Jackson A. Management of incidental findings during imaging research in “healthy” volunteers: current UK practice. Br J Radiol. 2012;85:11–21.View ArticleGoogle Scholar
- Illes J, Kirschen MP, Edwards E, Stanford LR, Bandettini P, Cho MK, et al. Incidental findings in brain imaging research. Science. 2006;311:783–4.View ArticleGoogle Scholar
- Wellcome Trust & Medical Research Council. Framework on the Feedback of Health-Related Findings in Research. Wellcome Trust & Medical Research Council; 2014.Google Scholar
- Hoggard N, Darwent G, Capener D, Wilkinson ID, Griffiths PD. The high incidence and bioethics of findings on magnetic resonance brain imaging of normal volunteers for neuroscience research. J Med Ethics. 2009;35:194–9.View ArticleGoogle Scholar
- Wardlaw JM, Davies H, Booth TC, Laurie G, Compston A, Freeman C, et al. Acting on incidental findings in research imaging. BMJ. 2015;351:h5190.View ArticleGoogle Scholar
- Presidential Commission for the Study of Bioethical Issues. Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Contexts. Presidential Commission for the Study of Bioethical Issues; 2013.Google Scholar
- Glaser B, Strauss A. The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago: Aldine Pub. Co; 1967.Google Scholar
- Bradley EH, Curry LA, Devers KJ. Qualitative data analysis for health services research: Developing taxonomy, themes, and theory. Health Serv Res. 2007;42:1758–72.View ArticleGoogle Scholar
- Bunnik EM, Vernooij MW. Incidental findings in population imaging revisited. Eur J Epidemiol. 2016;31:1–4.View ArticleGoogle Scholar
- World Medical Association (WMA) Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. Helsinki: WMA; 1964.Google Scholar
- Shoemaker JM, Cole C, Petree LE, Helitzer DL, Holdsworth MT, Gluck JP, Phillips JP. Evolution of universal review and disclosure of MRI reports to research participants. Brain Behav. 2016;6(3):e00428.View ArticleGoogle Scholar
- Council of Europe. Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. Oviedo: Council of Europe; 1997.Google Scholar
- Richardson HS, Belsky L. The ancillary-care responsibilities of medical researchers: An ethical framework for thinking about the clinical care that researchers owe their subjects. Hastings Cent Rep. 2004;34:25–33.View ArticleGoogle Scholar
- Richardson HS. Incidental findings and ancillary-care obligations. J Law Med Ethics. 2008;36:256–70. 211.View ArticleGoogle Scholar
- Miller FG, Mello MM, Joffe S. Incidental findings in human subjects research: what do investigators owe research participants? J Law Med Ethics. 2008;36:271–11.View ArticleGoogle Scholar
- Wellcome Trust & Medical Research Council. Assessing Public Attitudes to Health Related Findings in Research. London: Wellcome Trust & Medical Research Council; 2012.Google Scholar
- Kirschen MP, Jaworska A, Illes J. Subjects’ expectations in neuroimaging research. J Magn Reson Imaging. 2006;23:205–9.View ArticleGoogle Scholar
- Phillips JP, Cole C, Gluck JP, Shoemaker JM, Petree L, Helitzer D, et al. Stakeholder opinions and ethical perspectives support complete disclosure of incidental findings in MRI research. Ethics Behav. 2015;25:332–50.View ArticleGoogle Scholar
- Vernooij MW, Ikram MA, Tanghe HL, Vincent AJPE, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357:1821–8.View ArticleGoogle Scholar
- Bos D, Poels MM, Adams HH, Akoudad S, Cremers LG, Zonneveld HI, et al. Prevalence, clinical management, and natural course of incidental findings on brain MR images: the population-based Rotterdam Scan Study. Radiol. 2016;281(2):507-15.Google Scholar
- American College of Medical Geneticists (ACMG). ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet Med. 2015;17:68–9.View ArticleGoogle Scholar
- Geestelijke Gezondheidszorg Nederland (GGZ). Toelichting Wet op de Geneeskundige Behandelingsovereenkomst (WGBO). GGZ; 2013 [in Dutch].Google Scholar
- Nelson CA. Incidental findings in magnetic resonance imaging (MRI) brain research. J Law Med Ethics. 2008;36:315–9. 213.View ArticleGoogle Scholar
- Shoemaker JM, Holdsworth MT, Aine C, Calhoun VD, de La Garza R, Feldstein Ewing SW, et al. A practical approach to incidental findings in neuroimaging research. Neurology. 2011;77:2123–7.View ArticleGoogle Scholar
- Illes J, Desmond JE, Huang LF, Raffin TA, Atlas SW. Ethical and practical considerations in managing incidental findings in functional magnetic resonance imaging. Brain Cogn. 2002;50:358–65.View ArticleGoogle Scholar
- Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283:2701–11.View ArticleGoogle Scholar